Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.39 USD
0.1%
Market Closed
Updated:
May 12, 2024
Prestige Consumer Healthcare Inc
Accounts Payable
|
Prestige Consumer Healthcare Inc
Accounts Payable Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Accounts Payable
$39.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Accounts Payable
$8.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Accounts Payable
$3.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
4%
|
|
|
Pfizer Inc
NYSE:PFE
|
Accounts Payable
$6.7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Accounts Payable
$3.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Accounts Payable
$2.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
See Also
What is Prestige Consumer Healthcare Inc's Accounts Payable?
Accounts Payable
39.3m
USD
39.3m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Accounts Payable amounts to 39.3m USD.
What is Prestige Consumer Healthcare Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
-3%
-3%
Over the last year, the Accounts Payable growth was -39%. The average annual Accounts Payable growth rates for Prestige Consumer Healthcare Inc have been 11% over the past three years , -4% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
